AbbVie has announced its second major takeover deal in the space of a few days, offering $8.7 billion to buy central nervous system drug specialist Cerevel Therapeutics, which spun out of Pfizer ...

Cerevel Therapeutics’ Parkinson’s ... reinforcing its blockbuster potential and no doubt delighting AbbVie, which has agreed to buy the company in an $8.7 billion deal. Tavapadon is just ...